SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject4/23/2003 1:04:48 PM
From: richardred  Read Replies (1) of 724
 
NBSC-A nice fit-for-SPX-They bought Kendro a few years back

spx.com
A new diversified bio-player-SPX-The sale of INRANGE converts a non core
asset into $173mm of cash with no earnings loss and the exit of the Assa
Abloy JV and various properties will bring in another $100mm+ with little
earnings loss. Some of these proceeds will likely find their way into
further capital reductions or support a positive arbitrage into small
acquisitions that augment a core business.

Fisher still being sold off by major shareholder-
AOT-buying back it own stock
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext